Resource Center

Stories

 

 

 

The IRE Resource Center is a major research library containing more than 26,000 investigative stories — both print and broadcast.

These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need.

Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center.

 

 

 



Search results for "Food and Drug Administration" ...

  • The Evidence Gap

    The nations' medical bill last year exceeded $2.7 trillin -- nearly as much as the projected total cost of the Iraq war. If it were medical money well spend, there might be few cries to "reform" the American health care system. But by some estimates, one-third or more of the medical care received by patients in this country may be virtually worthless. The nation is wasting hundreds of billions of dollars each year on superfluous treatments -- money that otherwise could by spent, for example , on providing health insurance for every child, woman and man int his country who currently have no coverage. A team of science and business reporters from The New York Times set out to explain how and why the United States is spending so much on health care with so relatively little to show for the money, They discovered a gaping chasm between scientific evidence and the practice of medicine. In an in-depth series of articles, told through real doctors and patients, and based on information they dug up that was frequently unflattering to medical providers, companies and regulators, the Times team documented many disturbing instances of "The Evidence Gap."

    Tags: health care; CT angiograms; Avastin; cancer treatment; reckless spending; Food and Drug Administration; mammograms

    By Alex Berenson; Barry Meier; Gina Kolotz; Elizabeth Rosenthal; Andrew Pollack; Gardiner Harris; Reed Abelson

    New York Times

    2008

  • Chemical Fallout

    "The reporters exposed inept government programs that favor chemical makers over the needs of the public. They detailed conflicts of interest among regulators and uncovered new hidden threats for consumers. The newspaper tested common household plastics billed as "microwave safe" and found toxic levels of chemicals leaching from every item tested."

    Tags: chemicals; toxins; public safety; government protection; bisphenol A; Environmental Protection Agency; Food and Drug Administration;

    By Susanne Rust; Meg Kissinger

    Milwaukee Journal Sentinel

    2008

  • Unapproved Drugs

    The government is paying millions for risky medications that have never been reviewed for safety and effectiveness but are still covered under Medicaid, an Associated Press analysis of federal data has found. Tax payers have shelled out at least $200 million since 2004 for such drugs. Yet the Food and Drug Administration says unapproved prescription drugs are a public health problem, and some unapproved medications have been dozens of deaths. Millions of private patients are taking them as well, and their availability may create a false sense of security. The AP analysis found that Medicaid, which serves low-income people, paid nearly $198 million from 2004 to 2007 for more than 100 unapproved drugs. Data for 2008 were not available but unapproved drugs still are being sold. The AP checked the medications against FDA databases, using agency guidelines to determine if they were unapproved. The FDA says there may be thousands of such drugs on the market. The medications are mainly for common conditions like colds ad pain. They date back decades, before the FDA tightened its review of its review of drugs in the early 1960s. The FDA says it is trying to squeeze them from the market, but conflicting federal laws allow the Medicaid health program for low-income people to pay for them.

    Tags: Medicaid; unapproved medicine; medical reporting; Food and Drug Administration; prescription drugs; medical review

    By Ricardo Alonso-Zaldivar; Frank Bass

    Associated Press

    2008

  • Chantix: Miracle cure for dangerous drug?

    An investigation into the anti-smoking drug Chantix/Varenicline found many adverse reactions in the FDA's public database. The reactions included aggression, violent behavior and thoughts of suicide. "A follow report detailed how drugs are sent to market with minimal testing."

    Tags: Food and Drug Administration; medicine; anti-smoking; risk; Europe; drug testing; adverse reactions;

    By Bennett Cunningham; Stuart Boslow; Manuel Villela; Joshua Brown; Aaron Wische

    KTVT-TV (Dallas)

    2007

  • Fish Fraud

    "Focusing on red snapper, a pricey fish the Food and Drug Administration red-flags as commonly substituted, Fuller had DNA testing done on samples from Chicago restaurants: None, our testing results proved, was serving genuine red snapper."

    Tags: food; restaurant; DNA; red snapper; fish;

    By Janet Fuller

    Chicago Sun-Times

    2007

  • The Killer Cure

    Thousands of patients have died as a result of the Food and Drug Administration, along with drug companies, have failed to warn Americans about the dangers of methadone. People are overdosing on methadone, and federal officials hired a doctor on the payroll of a methdaone maker to report on the number of deaths each year.

    Tags: FDA; OD; poison; oxycontin; prescription drug; heroin; opium

    By Scott Finn; Tara Tuckwiller

    Gazette (Charleston, W.Va.)

    2006

  • Dangerous Remedy

    Robert Little of The (Baltimore) Sun reported that the U.S. Army has injected over 1000 soldiers wounded in Iraq with a medicine designed for hemophiliacs despite the fact that it is dangerous for people with normal blood. It can give them blood clots that could cause strokes and heart attacks. It costs $6000 per dose. Civilian doctors "have largely rejected it as a standard treatment for trauma patients." Army doctors say, in their experience, the drug saves lives by stopping hemorrhaging. Little says “Doctors in Iraq's emergency rooms, however, almost never care for their patients long enough to see firsthand whether blood clots or other complications have developed." Little reports that "the drug has never been subjected to a large-scale clinical trial to verify that it works and is safe for patients without hemophilia."

    Tags: military medical system; Iraq; coagulant; Institute for Surgical Research; Germany; military hospitals; Food and Drug Administration; FDA; U.S. Department of Defense; DoD; Marines; Assistant Secretary of Defense for Health Affairs; U.S. Army Surgeon General; HIPPA; actionable intelligence; Recombinant Activated Factor VII; Novo Nordisk; coagulopathic bleeding;

    By Robert Little

    Baltimore Sun

    2006

  • Ketek

    Dr. David Ross, who reviewed the safety of an antibiotic called Ketek for the Food and Drug Administration, tells the CBS Evening News that he warned them the drug was a "timebomb". Yet, the concerns were kept quiet, and the drug was approved, enjoying sales of $193 million worth in 2005. The drug's list of side effects, including possible liver problems, have been added to continuously since 2004. Senator Charles Grassley (R-IA) is conducting an investigation into the situation, and there is another congressional investigation of the drug and "possible misappropriation of CIA funding."

    Tags: Ketek; antibiotics; side effects; Food and Drug Administration

    By Armen Keteyian; Laura Strickler; Bert Rudman

    CBS News

    2006

  • Prescription for Trouble: Common drugs, hidden dangers. Tens of millions of people at risk.

    This article investigated twelve common types of prescription drugs that are linked to serious risks, including heart attacks, cancer, strokes and suicide. The risks were undetected or underestimated when the drugs were initially approved for use. Many of the drugs are still not properly disclosing the risks in advertisements. The article uncovers widespread problems in the drug safety system and proposes needed reform.

    Tags: medicine; drugs; FDA; health; drug companies; FOIA; side-effects; Food and Drug Administration; pharmaceuticals

    By Ronni Sandroff; Ron Buchheim; Doug Podolsky; Martin Romm

    Consumer Reports

    2006

  • Patch Problems

    A review of Food and Drug Administration records indicated that at least 12 women who used the birth-control patch died from blood clots in 2004, and that the risk of dying or suffering a survivable blood clot while using the device was about three times higher than while using birth control pills.

    Tags: birth control; Food and Drug Administation; death; blood clots

    By Martha Medoza

    Associated Press

    2005